This is an application to establish a Center for AIDS research (CFAR). The Center will be formed through a consortium of programs and shared resources of NYU Medical Center and the Public Health Research Institute (PHRI). The CFAR will consolidate, sustain, and enlarge a multi- disciplinary effort that has grown and developed since the earliest cases of AIDS were recognized and described at NYU Medical Center. The CFAR has as its foundation a strong research effort at the molecular level which includes active AIDS investigations in retrovirology, genetics, virology, immunology, and microbiology: and an unparalleled and varied patient population which has immunology and microbiology: and an unparalleled and varied patient population which has fostered large programs of AIDS epidemiology and testing of investigational therapeutic interventions for AIDS, ARC, and related syndromes. The CFAR will consolidate and formalize the loose association among the diverse programs currently in progress at NYU Medical Center.
Our specific aim for the CFAR is to construct a focal central resource which will attract and support AIDS investigators and provide program and shared resource units to enhance and strengthen ongoing AIDS basic and clinical research as well as provide the means for the development and stimulus of additional meritorious research that will ultimately expand our knowledge and understanding of AIDS. This will be accomplished in three ways: 1) through the initial formation of 7 interdisciplinary research programs and 8 shared resource facilities; 2) by expanding the research base through recruitment and development of promising AIDS researchers: and 3) by stimulating interdisciplinary collaboration and communication among basic science and clinical investigators involved in AIDS research. Since initial application was made for CFAR funding, nascent plans for the establishment of the New York City AIDS Research Center (NYARC) has been formalized. Major funding commitments have been made to NYARC by the City of New York Department of Health ($3 Million) for construction and the Aaron Diamond Foundation ($3 Million) for support of the Director and his/her senior staff, for which a search committee is currently active. NYARC will be a partially congruent and mutually reinforcing organization, which will supplement the activities of the CFAR.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027742-02
Application #
3101054
Study Section
Special Emphasis Panel (SRC (28))
Project Start
1989-09-01
Project End
1994-06-30
Budget Start
1990-07-01
Budget End
1991-06-30
Support Year
2
Fiscal Year
1990
Total Cost
Indirect Cost
Name
New York University
Department
Type
Schools of Medicine
DUNS #
004514360
City
New York
State
NY
Country
United States
Zip Code
10012
Gornalusse, German G; Mummidi, Srinivas; Gaitan, Alvaro A et al. (2015) Epigenetic mechanisms, T-cell activation, and CCR5 genetics interact to regulate T-cell expression of CCR5, the major HIV-1 coreceptor. Proc Natl Acad Sci U S A 112:E4762-71
Miller, Elizabeth A; Gopal, Ramya; Valdes, Vanessa et al. (2015) Soluble CD40 ligand contributes to dendritic cell-mediated T-cell dysfunction in HIV-1 infection. AIDS 29:1287-96
Phelan, Joan A; Abrams, William R; Norman, Robert G et al. (2014) Design aspects of a case-control clinical investigation of the effect of HIV on oral and gastrointestinal soluble innate factors and microbes. PLoS One 9:e112901
Sivapalasingam, Sumathi; Mendillo, Megan; Ahmed, Aabid et al. (2014) The importance of caregivers in the outcome of pediatric HIV management, Mombasa, Kenya. AIDS Care 26:425-33
Weiden, Michael D; Hoshino, Satomi; Levy, David N et al. (2014) Adenosine deaminase acting on RNA-1 (ADAR1) inhibits HIV-1 replication in human alveolar macrophages. PLoS One 9:e108476
Ryndak, Michelle B; Singh, Krishna K; Peng, Zhengyu et al. (2014) Transcriptional profiling of Mycobacterium tuberculosis replicating ex vivo in blood from HIV- and HIV+ subjects. PLoS One 9:e94939
Weiser, Keren; Barton, Meredith; Gershoony, Dafna et al. (2013) HIV's Nef interacts with ?-catenin of the Wnt signaling pathway in HEK293 cells. PLoS One 8:e77865
O'Brien, Meagan; Montenont, Emilie; Hu, Liang et al. (2013) Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: a pilot study. J Acquir Immune Defic Syndr 63:280-8
Rich, Josiah D; DiClemente, Ralph; Levy, Judith et al. (2013) Correctional facilities as partners in reducing HIV disparities. J Acquir Immune Defic Syndr 63 Suppl 1:S49-53
Alvarez, Yelina; Tuen, Michael; NĂ das, Arthur et al. (2012) In vitro restoration of Th17 response during HIV infection with an antiretroviral drug and Th17 differentiation cytokines. AIDS Res Hum Retroviruses 28:823-34

Showing the most recent 10 out of 254 publications